Marc Bonaca MD MPH
@MarcBonaca
Followers
2K
Following
570
Media
38
Statuses
318
Cardiology and Vascular Medicine Specialist. Executive Director of CPC Clinical Research. Director of Vascular Research. University of Colorado.
Denver, CO
Joined August 2018
Many PAD patients fear a heart attack but have never heard of #acutelimbischemia #ALI. The risk is similar to MI and Stroke and the outcomes are poor. Do you talk to your #PAD patients about ALI? #peripheralarterydisease
1
16
66
The American Journal of Managed Care, Colorado Prevention Center, & the University of Colorado, present: Institute for Value-Based Medicine, Population Health Lipid Risk Management Forum & Dinner, Chaired by Dr. Marc Bonaca! More info/to register: https://t.co/O4zpMteTBa
0
3
8
Great to meet new colleagues & see old friends @CUAnschutz for final cardiology #Grand Rounds of 2023-24 #majesticWest #RockyMountainWild
@cpcresearch #cardiometabolic
@MarcBonaca (πΈ credit) @kofi_larry #ConnieHess @StephenWaldoMD
0
3
44
What is #JACC about? Listen as Editor-in-Chief Dr. Harlan Krumholz details why JACC is focused on impact π₯ and ensuring the future of cardiovascular health around the globe π is better than the past. Watch β¬οΈ & learn more here: https://t.co/StARtMBnrh
@hmkyale
0
2
5
π 2023 Impact Factors are in! The #JACCJournals portfolio remains the strongest among the major cardiovascular portfolios of peer reviewed journals. All eligible JACC Journals ranked in the top 18. More: https://t.co/HvpWDG5Hi8
#Cardiology
0
5
21
Vascular medicine expert @MarcBonaca gave us his perspective on the new #PAD guidelines β¬οΈ https://t.co/LtholIlUCn
healio.com
A new guideline on lower-extremity peripheral artery disease encouraged managing care with a multispecialty team and having patients undergo structured exercise programs. The guideline, developed by...
0
2
4
Our analysis from VOYAGER-PAD trial published in @CircAHA. New data on Rivaroxaban plus Aspirin in PAD+CAD patients undergoing LER. Thanks to EC Members and Co-Authors! #VascularMedicine
@MarcBonaca @cpcresearch @CUDeptMedicine @CUCardiology. https://t.co/CmLTPh1Mb8
2
4
19
A weekend well spent discussing plans for preventing and for improving outcomes for patients with CLTI with the top guns in this field @World_fvs @Vascular_India @VascularSVS @ESVSmembership @DGArmstrong @jmills1955 @RMotaganahalli @drvsbedi @RKTvascular
1
2
20
1/ Released today, the 2024 Peripheral Artery Disease Guideline was developed by AHA and @ACCIntouch in collaboration with and endorsed by: @AACVPR
@APMA
@abcardio1
@SCAI
@SVM_tweets
@for_svn
@VascularSVS
@SIRspecialists
@VESurgery π· The process for multi-society involvement
3
13
25
We just wrapped our final press conference for #ACC24! β
A big thank you to discussants Dr. @MarcBonaca, Dr. @jennifer_rymer and @kim_guibone, DNP, for their excellent remarks to close out the press program.
0
2
7
You have found it! Your source for free CE/CME via Twitter! Each program provides 0.5h credit for #physicians, #pharmacists, and #nurses on topics of interest in the cardiometabolic space. Expert authors! See archived programs (and still earn credit) at https://t.co/U6Mo1oSwIh.
3
15
43
0
5
14
Next stop π in B309 is Kevin Rogers presenting - Risk of Adverse Events in Peripheral Artery Disease Patients with Below-Knee Disease: An Analysis from the VOYAGER-PAD Catheter-Based Angiographic Core Lab at 8:49 AM ET! ππ
0
1
2
@JJheart_doc @MidAmericaHeart @MkosiborodMD @MarcBonaca @JavedButler1 @RyanTedfordMD @robmentz @dranulala @noshreza @mvaduganathan @AlexMebazaa Next up, CONFIRMATION-HF.
0
1
7
@MidAmericaHeart is proud to announce we randomized first patient in REDEFINE-HF, an international, randomized, placebo-controlled, event-driven trial of finerenone for the treatment hospitalized heart failure patients with HFmrEF/HFpEF. https://t.co/UGvCHOc7If
3
8
52
Super excited about the multispecialty faculty (VS, IR, IC, VM) - all passionate about education! Whether you want to set yourself up for success in managing your vascular patients or simply win vascular jeopardy, we are ready for you! Travel stipend for 1st time attendees π
Are you interested in #Cardiology #VascularSurgery #VascularMedicine #IR ? Donβt miss this amazing learning opportunity for #residents #fellows #APPs ! Registration is now OPEN! Join #SVM & register today https://t.co/SqgoC4MlQt
@heatherlgornik @adityasharmamd @RKolluriMD
0
7
20
Great pleasure to present data from VOYAGER-PAD trial on Fragile patients at #AHA23. @AHAMeetings @PVDCouncil @cpcresearch @MarcBonaca
0
5
17
A scary map! #PADCollaborative Calling all of you to be a FORCE to fight against the amputation epidemic #AHA23 #PADCollaborative #CLTI #Amputationmap @PVDCouncil @AHAScience @AHAMeetings #structuralracism #ampute #PAD @hmpVDM @VMJ_SVM #SVM
1
9
27